{"id":"W2907895732","doi":"10.3324/haematol.2018.205948","title":"Gemtuzumab ozogamicin in acute myeloid leukemia: act 2, with perhaps more to come","year":2018,"lang":"en","type":"editorial","venue":"Haematologica","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Gemtuzumab ozogamicin; Myeloid leukemia; Calicheamicin; Medicine; Leukemia; Oncology; Internal medicine; CD33; Biology; Genetics; Stem cell","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005430123,0.002538689,0.003332991,0.002124284,0.001578127,0.005070476,0.002730783,0.01145269,0.006541301],"category_scores_gemma":[0.01577595,0.0008957074,0.002348951,0.001058964,0.001459827,0.003826012,0.001087008,0.01705176,0.00524841],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002247478,"about_ca_system_score_gemma":0.002486978,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001213756,"about_ca_topic_score_gemma":0.002810058,"domain_scores_codex":[0.9970522,0.0006216175,0.0005208509,0.0003447624,0.001213273,0.0002472967],"domain_scores_gemma":[0.9905307,0.003543671,0.0008150932,0.0002553256,0.003346222,0.001509017],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.000138505,0.00002167921,0.00004578914,0.000443507,0.00004940921,0.0001560872,0.000009136367,0.00003341027,0.00008996142,0.0002828011,0.98729,0.01143973],"study_design_scores_gemma":[0.0003396164,0.0001390797,0.0004891581,0.0008264899,0.0002678692,0.0006140982,0.00004063422,0.0002383887,0.0001990187,0.001001096,0.9958107,0.00003379922],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"editorial","genre_gemma":"editorial","genre_scores_codex":[0.00006894104,0.02135924,0.0001114278,0.03419301,0.9433501,0.00001362441,0.00004061254,0.0000461954,0.0008168519],"genre_scores_gemma":[0.0005232661,0.01168115,0.0001232517,0.03194638,0.9515202,0.00001576677,0.00003213508,0.0000223748,0.004135381],"genre_candidate":"editorial","genre_consensus":"editorial","teacher_disagreement_score":0.01145269,"threshold_uncertainty_score":0.02871758,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01562678945501358,"score_gpt":0.3132534552288764,"score_spread":0.2976266657738629,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}